How can big data improve humanity?
April 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data
Alexander Hitchcock and Eleonora Harwich, researchers at UK think tank Reform, discuss the increasing importance of big data in the …
AbbVie’s experimental cancer drug hits wall in clinical study
April 20, 2017Research and Development AbbVie, AstraZeneca
AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary endpoints. …
New drug study successfully halts neurodegeneration in mice
April 20, 2017Research and Development Alzheimer's, Parkinson's, trazodone
A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified methods to prevent neurodegeneration …
Alpine Immune Sciences boosts prospects with Nivalis merger
April 20, 2017Sales and Marketing Alpine Immune Sciences, Nivalis Therapeutics, merger
Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The merger sees Alpine …
Investigational ImmunoGen drug gives hope against platinum-resistant ovarian cancer
April 20, 2017Research and Development Cancer, Immunogen, ovarian cancer
Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an …
‘World Hemophilia Day’ marked by release of data
April 20, 2017Medical Communications, Research and Development Roche, Shire, haemophilia
‘World Hemophilia Day’ occurred on 17 April and the day was marked by the release of data from two companies …
New prognostic tool accurately predicts kidney failure risk
April 19, 2017Research and Development diabetes, kidney failure
Researchers from the Joslin Diabetes Center (JDC) have developed a prognostic tool which they claim can accurately predict the risk …
Cannabidiol reduces seizures by half in severe epilepsy, study suggests
April 19, 2017Research and Development Lennox-Gastaut syndrome, cannabidiol
A new large-scale study from the American Academy of Neurology has suggested that cannabidiol, a molecule derived from cannabis without …
Frog mucus may offer protection against flu virus
April 19, 2017Research and Development Flu virus, influenza virus
Fairy tales about kissing frogs may have been onto something after all, maybe not to acquire a prince but possibly …
Behavioural intervention reduces need for antipsychotics in dementia treatment
April 19, 2017Research and Development antipsychotic, dementia
A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …
Pfizer launches Healthcare Hub to support healthtech startups
April 19, 2017Medical Communications, Research and Development HealthTech, Pfizer, healthcare
Pfizer has announced the launch of ‘Pfizer Healthcare Hub: London’, a project that aims to help startups, focusing on the …
How regulators and NGOs are bringing the threat of fake medicines to light
April 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, fake drugs
If recent world events are anything to go by, there is a growing awareness that anything read on the internet …
Allergan and Novartis join forces to develop NASH combo therapy
April 18, 2017Manufacturing and Production, Research and Development Allergan, Novartis, nash
Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis …
FDA warns of dangers of Hyland’s homeopathic teething tablets as recall is issued
April 18, 2017Manufacturing and Production, Sales and Marketing FDA, Hyland, recall
After months of FDA warnings, Hyland has finally issued an official voluntary recall of its homeopathic teething tablets, with the …
Circassia stumbles with allergy treatments at clinical trial stage, again
April 18, 2017Manufacturing and Production, Research and Development, Sales and Marketing Circassia
Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …
Roche’s drug scores expanded FDA indication in advanced bladder cancer
April 18, 2017Manufacturing and Production, Sales and Marketing Genentech, Roche, tecentriq
Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after …
‘Smart bandages’ could offer real-time wound feedback
April 18, 2017Manufacturing and Production, Research and Development, Sales and Marketing Swansea University, smart bandage
The problem with bandages is that often we do not know how well a wound has healed under them until …
FDA warning slams St Jude’s “inadequate response” to device failures
April 13, 2017Medical Communications, Sales and Marketing FDA, st jude medical
St Jude Medical has been hit with a warning letter from the FDA over the medical device manufacturer’s failure to …
Rebiotix delivers a gut bug PUNCH in C. diff trial
April 13, 2017Research and Development C diff, C. diff, Rebiotix, microbiome
Rebiotix is one a new breed of companies that aims to use the human body’s microbiome to treat illnesses and …
Antiparasitic drug repurposed for treatment of brain tumours
April 13, 2017Research and Development Low-grade glioma, parasitic pinworms, tumour
Researchers from The Feinstein Institute for Medical Research’s Karches Center for Oncology Research has had a research breakthrough by taking …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
